HALTIGRI
DEAD

Serial Number

90072528

Owner

TRAVERE THERAPEUTICS, INC.

Attorney

Jared M. Barrett

Filing Date

Jul 24, 2020

Add to watchlist:

No watchlists yet
View on USPTO

HALTIGRI Trademark

Serial Number: 90072528

HALTIGRI is a trademark filed by TRAVERE THERAPEUTICS, INC. on July 24, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

TRAVERE THERAPEUTICS, INC. (67 trademarks)

SUITE 300
SAN DIEGO, CA 92130

Entity Type: 03

RETROPHIN, INC. (70 trademarks)

Suite 200
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

July 24, 2020

Registration Date

Not Registered

Published for Opposition

January 19, 2021

Goods & Services

pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 18, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 18, 2021 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 16, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 19, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 19, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 30, 2020 NONP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 23, 2020 ASGN
ASSIGNED TO LIE
Dec 14, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 14, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2020 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Nov 16, 2020 GPRN
PRIORITY ACTION E-MAILED
Nov 16, 2020 GPRA
PRIORITY ACTION WRITTEN
Nov 16, 2020 CPRA
ASSIGNED TO EXAMINER
Nov 10, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2020 NWOS
NEW APPLICATION ENTERED
Jul 28, 2020 NWAP